logo

For the Inventor, By the Inventor

Oxford, MS, United States of America

Mahmoud Ahmed ElSohly

This inventor holds 31 USPTO granted patents and 2 published patent applications, primarily in Cannabinoid Research. Top assignees: The University of Mississippi, Elsohly Laboratories, Incorporated, Saladax Biomedical Inc.. Active years: 1990-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahmoud Ahmed ElSohly. Retrieved from https://idiyas.com/inventor/mahmoud-ahmed-elsohly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 31 

% Patents Active = 96.8

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 312(Granted Patents)


Company Filing History:

goldMedal23 out of 158 
 
The University of Mississippi
 patents
silverMedal2 out of 2 
 
Elsohly Laboratories, Incorporated
 patents
bronzeMedal2 out of 28 
 
Saladax Biomedical Inc.
 patents
4. 1 out of 3 
 
Cole Research & Design, LLC
 patents
5. 1 out of 1 
 
Hapten Sciences, Inc.
 patent
6. 2 out of 834,601 
Other
 patents

Years Active: 1990-2023

Loading Chart...
Areas of Expertise:
Cannabinoids
Dihydroartemisinine
Immunoassay
THC Esters
Anticancer Agents
Resveratrol Esters
Microalgae
Bioavailability
Poison Ivy Dermatitis
Test Panels
Isolation Techniques
Analogs
31 patents (USPTO):Explore Patents
1. 11666667 - Patches comprising urushiol, test panels comprising the same, and methods of using the same (2023-06-06),
2. 11596617 - Biologically active cannabidiol analogs (2023-03-07),
3. 11344525 - Biologically active cannabidiol analogs (2022-05-31),
4. 11337952 - Biologically active cannabidiol analogs (2022-05-24),
5. 11337951 - Biologically active cannabidiol analogs (2022-05-24),
6. 11337950 - Biologically active cannabidiol analogs (2022-05-24),
7. 11117852 - Isolation of pure cannabinoids from (2021-09-14),
8. 10709681 - Biologically active cannabidiol analogs (2020-07-14),
9. 10099995 - Resveratrol esters (2018-10-16),
10. 9630941 - Compositions containing delta-9-THC-amino acid esters and process of preparation (2017-04-25),
11. 9408822 - Compositions for prevention/prophylactic treatment of poison ivy dermatitis (2016-08-09),
12. 9029417 - Compositions for prevention/prophylactic treatment of poison ivy dermatitis (2015-05-12),
13. 8809261 - Compositions containing delta-9-THC-amino acid esters and process of preparation (2014-08-19),
14. 8486998 - Compositions for prevention/prophylactic treatment of poison ivy dermatitis (2013-07-16),
15. 7842720 - Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities (2010-11-30),

Title: Mahmoud Ahmed ElSohly - Pioneering Inventor from Oxford, MS

Introduction: Mahmoud Ahmed ElSohly is a renowned inventor hailing from Oxford, Mississippi, known for his groundbreaking contributions to the field of pharmaceuticals and cannabis research.

Latest Patents: ElSohly holds several patents related to the extraction and analysis of cannabinoids, as well as innovative drug delivery systems for medical cannabis products.

Career Highlights: With a distinguished career spanning several decades, ElSohly has been instrumental in advancing the understanding of the medicinal properties of cannabis and has played a key role in the development of standardized cannabis-based medications.

Collaborations: Throughout his career, ElSohly has collaborated with leading research institutions, pharmaceutical companies, and government agencies to further research in the field of cannabis-based therapeutics.

Conclusion: Mahmoud Ahmed ElSohly's pioneering work has significantly impacted the pharmaceutical and medical cannabis industries, making him a respected figure in the field of drug development and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…